Download PDF
AJP Rep 2011; 01(02): 105-110
DOI: 10.1055/s-0031-1285984
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Polymicrogyria and Congenital Parvovirus B19 Infection

Grant S. Schulert
1   Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee
,
William F. Walsh
1   Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee
2   Division of Neonatology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee
,
Jörn-Hendrik Weitkamp
1   Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee
2   Division of Neonatology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee
› Author Affiliations
Further Information

Publication History

Publication Date:
02 August 2011 (online)

   Permissions and Reprints

Abstract

Fetal parvovirus B19 infection causes anemia, hydrops, and pregnancy loss but is generally not considered teratogenic. Nevertheless, disturbances of neuronal migration have been described with congenital parvovirus infection. We evaluated a term infant with congenital parvovirus disease and polymicrogyria. We compared this case with four other reports of central nervous system disease after birth to parvovirus-infected mothers. After an extensive diagnostic evaluation, this infant was found to have congenital parvovirus disease with severe anemia and nonimmune hydrops as well as extensive polymicrogyria. Although rare, this report and literature review suggest that parvovirus B19 has the potential to disrupt normal neurodevelopment. We suggest that infants with severe congenital parvovirus infection have close developmental surveillance and if symptomatic undergo neuroimaging to assess for disorders of neuromigration.

Keywords

Parvovirus - polymicrogyria - teratogen - congenital infection
 

  • References

  • 1 Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-597
    CrossrefPubMedGoogle Scholar
  • 2 Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004; 24: 513-518
    CrossrefPubMedGoogle Scholar
  • 3 Kumar ML, Abughali NF. Perinatal parvovirus B19 infection. NeoReviews 2005; 6: 32-37
    CrossrefPubMedGoogle Scholar
  • 4 Pistorius LR, Smal J, de Haan TR , et al. Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection. Fetal Diagn Ther 2008; 24: 491-494
    CrossrefPubMedGoogle Scholar
  • 5 Guerrini R, Parrini E. Neuronal migration disorders. Neurobiol Dis 2010; 38: 154-166
    CrossrefPubMedGoogle Scholar
  • 6 Leventer RJ, Jansen A, Pilz DT , et al. Clinical and imaging heterogeneity of polymicrogyria: a study of 328 patients. Brain 2010; 133 (Pt 5) 1415-1427
    CrossrefPubMedGoogle Scholar
  • 7 Brown KE, Green SW, Antunez de Mayolo J , et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994; 343: 895-896
    CrossrefPubMedGoogle Scholar
  • 8 Heegaard ED, Hasle H, Clausen N, Hornsleth A, Kerndrup GB. Parvovirus B19 infection and Diamond-Blackfan anaemia. Acta Paediatr 1996; 85: 299-302
    CrossrefPubMedGoogle Scholar
  • 9 Katz VL, McCoy MC, Kuller JA, Hansen WF. An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. Am J Perinatol 1996; 13: 43-45
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Isumi H, Nunoue T, Nishida A, Takashima S. Fetal brain infection with human parvovirus B19. Pediatr Neurol 1999; 21: 661-663
    CrossrefPubMedGoogle Scholar
  • 11 Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998; 105: 174-178
    CrossrefPubMedGoogle Scholar
  • 12 Nagel HTC, de Haan TR, Vandenbussche FPHA, Oepkes D, Walther FJ. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 2007; 109: 42-47
    CrossrefPubMedGoogle Scholar
  • 13 Dembinski J, Haverkamp F, Maara H, Hansmann M, Eis-Hübinger AM, Bartmann P. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG 2002; 109: 1232-1234
    CrossrefPubMedGoogle Scholar
  • 14 Savage AH, Anderson BL, Simhan HN. The safety of prolonged indomethacin therapy. Am J Perinatol 2007; 24: 207-213
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Johnson RT. Viral infections and malformations of the nervous system. Birth Defects Orig Artic Ser 1971; 7: 56-63
    PubMedGoogle Scholar